03-06-2020, 3.5 Million Share Institutional Buy-In tells only a snippet of the overall story with this dream stock.
sec.report/Document/0001104659-20-029961/a20-11569_2sc13g.htm
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market:
COCP is to Treatment what
IBIO is to Vaccines or what
OPK is to Testing.
COCP has completed all the financing and funding needed with two public offerings recently and are now aggressively pursing the development of Novel Anitiviral Compounds for treatment of any Corona infections including COVID-19
They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.
Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position
sec.report/Document/0001104659-20-029961/a20-11569_2sc13g.htm
To get the real grasp of what we have here, look to my previous post and take in this analogy as deeply as possible:
In the Coronavirus Market:
They have exclusive patent rights to the treatment and are in the process of advancing it quickly through a preclinical trial program.
Shorts will continue to write articles to downplay these facts as much as possible because the stock has a HUGE short position
免責聲明
這些資訊和出版物並非旨在提供,也不構成TradingView提供或認可的任何形式的財務、投資、交易或其他類型的建議或推薦。請閱讀使用條款以了解更多資訊。
